On April 22, 2024, John M. Siebert, Ph.D. informed Supernus Pharmaceuticals, Inc. that he has decided to retire from the Company's Board of Directors (the "Board"), effective at the Company's Annual Meeting of Stockholders in June 2024, and therefore is not standing for re-election at the Annual Meeting. He indicated that his decision is not the result of any disagreement with the Company.